|
|
? |
AFRICA: Agreement to slow spread of HIV
JOHANNESBURG, 1 April (PLUSNEWS) - International manufacturer of health care products, Johnson and Johnson (J&J), will give away rights to an experimental microbicide gel to developing countries.
In a recent announcement, J&J subsidiary Tibotec Pharmaceuticals agreed to hand over development of the vaginal gel, which could prevent HIV infection among women and is in early-stage human testing, to the International Partnership for Microbicides (IPM), a non-profit organisation.
According to a Canadian newspaper, The Record, IPM estimated it would spend up to US $100 million to test the gel, and may reformulate it into a differently administered product, such as a vaginal ring.
"This agreement demonstrates that the public and private sectors can come together to confront the global HIV/AIDS pandemic and work to save women's lives," Zeda Rosenberg, CEO of IPM, said.
[ENDS]
MORE NEWS BRIEFS
|
|
? |
|
[Back] [Home Page]
Click here to send any feedback,
comments or questions you have about IRIN's Website or if you prefer you
can send an Email to [email protected]
The material contained on this Web site comes to
you via IRIN, a UN humanitarian information unit, but may not necessarily
reflect the views of the United Nations or its agencies. If you re-print,
copy, archive or re-post any item on this site, please retain this credit
and disclaimer. Quotations or extracts should include attribution to the
original sources. All graphics and Images on this site may not be
re-produced without the express permission of the original owner. All
materials copyright © UN Office for the Coordination of Humanitarian
Affairs 2004
|
